CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles

• Auteurs principaux: Wei-Jing Dai (Auteur), Li-Yao Zhu (Auteur), Zhong-Yi Yan (Auteur), Yong Xu (Auteur), Qi-Long Wang (Auteur), Xiao-Jie Lu (Auteur)
• Format: Livre
• Publié: Elsevier, 2016-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Owing to its easy-to-use and multiplexing nature, the genome editing tool CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats (CRISPR) associated nuclease 9) is revolutionizing many areas of medical research and one of the most amazing areas is its gene therapy potentials. Previou...